Cipher appoints VP of portfolio development
This article was originally published in Scrip
Cipher Pharmaceuticals, a Canadian drug development company which commercialises formulations of marketed molecules, has appointed John MacInnis vice-president of portfolio development and licensing. Mr MacInnis will be responsible for identifying and evaluating pipeline products and technologies, and pursuing strategic alliances and partnerships for the company's drugs in targeted markets. He most recently served as vice-president of business development at the consulting firm Kromite.